Grifols SA (GRFS)
9.70
+0.63
(+6.95%)
USD |
NASDAQ |
Nov 14, 13:00
Grifols Price: 9.70 for Nov. 14, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2024 | 9.16 | 9.275 | 9.04 | 9.07 | 441458.0 |
| Nov 12, 2024 | 9.27 | 9.27 | 9.040 | 9.10 | 442288.0 |
| Nov 11, 2024 | 9.45 | 9.51 | 9.07 | 9.32 | 669454.0 |
| Nov 08, 2024 | 9.96 | 9.96 | 9.46 | 9.49 | 1.408M |
| Nov 07, 2024 | 9.26 | 9.94 | 9.12 | 9.50 | 2.063M |
| Nov 06, 2024 | 9.04 | 9.12 | 8.86 | 9.05 | 807440.0 |
| Nov 05, 2024 | 8.74 | 9.38 | 8.694 | 9.29 | 1.336M |
| Nov 04, 2024 | 8.92 | 8.96 | 8.775 | 8.80 | 472749.0 |
| Nov 01, 2024 | 8.74 | 8.855 | 8.74 | 8.84 | 715154.0 |
| Oct 31, 2024 | 8.62 | 8.755 | 8.51 | 8.69 | 1.370M |
| Oct 30, 2024 | 8.44 | 8.795 | 8.38 | 8.77 | 1.268M |
| Oct 29, 2024 | 8.73 | 8.73 | 8.11 | 8.20 | 1.585M |
| Oct 28, 2024 | 8.39 | 8.56 | 8.30 | 8.34 | 602408.0 |
| Oct 25, 2024 | 8.80 | 8.85 | 8.725 | 8.73 | 504574.0 |
| Oct 24, 2024 | 8.77 | 8.87 | 8.61 | 8.86 | 581868.0 |
| Oct 23, 2024 | 8.80 | 8.90 | 8.63 | 8.83 | 426596.0 |
| Oct 22, 2024 | 8.71 | 8.83 | 8.65 | 8.82 | 544023.0 |
| Oct 21, 2024 | 8.70 | 8.74 | 8.51 | 8.57 | 280141.0 |
| Oct 18, 2024 | 8.54 | 8.67 | 8.44 | 8.65 | 410319.0 |
| Oct 17, 2024 | 8.44 | 8.64 | 8.42 | 8.59 | 312767.0 |
| Oct 16, 2024 | 8.53 | 8.595 | 8.44 | 8.49 | 456025.0 |
| Oct 15, 2024 | 8.56 | 8.565 | 8.47 | 8.51 | 600263.0 |
| Oct 14, 2024 | 8.43 | 8.755 | 8.41 | 8.58 | 544462.0 |
| Oct 11, 2024 | 8.52 | 8.625 | 8.455 | 8.59 | 638162.0 |
| Oct 10, 2024 | 8.66 | 8.66 | 8.52 | 8.63 | 371023.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.47
Minimum
Mar 06 2024
25.63
Maximum
Feb 21 2020
12.77
Average
11.05
Median
Nov 29 2021
Price Benchmarks
| Cellectis SA | 1.90 |
| Adaptimmune Therapeutics PLC | 0.6131 |
| Akari Therapeutics PLC | 2.24 |
| Biodexa Pharmaceuticals PLC | 4.88 |
| Verona Pharma PLC | 35.92 |
Price Related Metrics
| PE Ratio | 30.56 |
| PS Ratio | 0.8900 |
| PEG Ratio | 6.707 |
| Price to Book Value | 1.103 |
| Earnings Yield | 3.27% |
| Market Cap | 6.592B |
| PEGY Ratio | 6.707 |
| Operating PE Ratio | 5.795 |
| Normalized PE Ratio | 27.89 |